市場調査レポート
商品コード
1571366

医療セカンドオピニオンの市場規模と予測、世界・地域シェア、動向、および成長機会分析:疾患別、サービスプロバイダー別、地域別

Medical Second Opinion Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Condition, Service Providers, and Geography


出版日
ページ情報
英文 135 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
医療セカンドオピニオンの市場規模と予測、世界・地域シェア、動向、および成長機会分析:疾患別、サービスプロバイダー別、地域別
出版日: 2024年10月08日
発行: The Insight Partners
ページ情報: 英文 135 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医療セカンドオピニオン市場は2023年の53億3,000万米ドルから成長し、2031年には154億米ドルに達すると予測されており、2023年から2031年のCAGRは14.2%と予測されています。医療セカンドオピニオン市場の成長は、より良い治療結果を重視する傾向の高まりと、ヘルスケアコストの最適化に対する嗜好の高まりに起因しています。

医療セカンドオピニオンとは、患者が診断された症例、治療、病状について、別の医療提供者による専門的な評価や査定を求めるプロセスです。これにより、患者は診断を確認し、代替治療の選択肢を探し、自分の健康に関して下す決定について安心することができます。セカンドオピニオンを得ることは、重篤な症状や複雑な医療ケース、最初に受けた勧めに対して患者が不安を感じている場合などに特に当てはまる。セカンドオピニオンを得ることは、患者により多くの情報を与え、健康状態に関する視点を与えることで、患者に力を与えることになります。

2023年の世界の医療セカンドオピニオン市場では、北米が大きなシェアを占めています。北米の医療セカンドオピニオン市場は、米国、カナダ、メキシコに区分されます。小児人口における呼吸器疾患の症例の増加や医療機器への投資の増加は、予測期間中に北米の医療セカンドオピニオン市場の成長を加速させると予測されるいくつかの要因の一つです。

北米では、米国が医療セカンドオピニオン市場で大きなシェアを占めています。同国における市場の成長は、主にがんの有病率の増加が原動力となっています。同国ではがんが死因の第2位を占めています。米国がん協会によると、2022年には国内で190万人以上が新たにがんと診断され、約60万9,360人が死亡しました。さらに、2024年には米国で200万人以上ががんと診断されると予想されています。誤診されるがん症例の増加とその悪影響が、医療セカンドオピニオンの需要を押し上げています。

ジョンズホプキンス大学の調査によると、米国では毎年4,000件もの手術ミスが発生しています。さらに、「死亡につながる医療過誤トップ10」という調査によると、米国では毎年7,000~9,000人の患者が投薬ミスにより死亡しています。2023年7月に発表された論文"Burden of serious harms from diagnostic error in the USA "によると、毎年約795,000人の米国人が重篤な疾患の誤診により苦しんでいます。このような医療過誤の多さは、国の医療セカンドオピニオンの必要性を急増させると予想されます。

2017年、UnitedHealthcareは2nd.MDと協力し、会員向けの専門家による医療意見サービスを無料で提供しました。2nd.MDは、医療意見サービス分野の専門家に仮想的に接続し、症例を検討してセカンドオピニオンを提供します。さらに、治療計画の検討、診断の確認、問い合わせへの対応、迅速なセカンドオピニオンの提供のために、医師と患者をつなぐことで患者を支援する組織もいくつかあります。例えば、ワールドケアインターナショナル社は、世界中の保険加入者に対し、重篤な病気に対する医療セカンドオピニオンのゴールドスタンダードを提供しています。このサービスでは、がん、心血管疾患、神経疾患、筋骨格系疾患、血液疾患など、100種類以上の重症疾患をカバーしています。

医療コンサルティングサービスのデジタル化が今後の市場機会をもたらす

医療サービスとデジタル・プラットフォームの統合が進むにつれ、デジタル診察の人気と受容性が高まっています。このデジタルプラットフォームにより、患者は病院や診療所を訪れることなく、セカンドメディカルオピニオンを得ることができます。このサービスにより、患者の利便性、患者体験の向上、効果的なコスト管理が可能になります。デジタルプラットフォームを導入することで、患者は遠隔地からでも医療専門家にアクセスしやすくなり、診察を受けることができます。ソフトウェア開発企業とヘルスケア機関とのコラボレーションやパートナーシップの増加は、医療コンサルティングサービスのデジタル化を加速させています。例えば、2021年10月、NorthShore University HealthSystemはTytoCareと提携し、医療提供者が遠隔医療を利用して患者の診断や治療を行えるようにしました。ノースショアはシカゴ都市圏の住民にサービスを提供し、6つの病院を運営しています。2021年10月、シグナヘルスプランは、デジタルファーストのプライマリケア、皮膚科、行動ケア、緊急ケアなど、対象となるバーチャルケアサービスへのアクセスを大幅に拡大すると発表しました。医療コンサルティングサービスのデジタル化の進展は、今後数年間の医療セカンドオピニオン市場の成長に寄与すると予想されます。

医療セカンドオピニオン市場競合情勢と主な発展

Medisense Healthcare Solutions Pvt. Ltd.、Second Opinion International、Elite Medical Services、The Cigna Group、Helsana、WorldCare、Vidal Health Insurance TPA Pvt Ltd、Medix、2nd.MD、Axa SA、Teladoc Health Inc、DoctorSpring Pvt. Ltd、USARAD Holdings Inc(SecondOpinions.com)、Cleveland Clinic、Included Health, Inc.(Partners Healthcare)、Stanford Health Care、Royal Doctorsなどが医療セカンドオピニオン市場で事業を展開する主要企業です。

米国食品医薬品局、American College of Allergy Asthma and Immunology、The Barcelona Institute for Global Health、Our World in dataなどは、医療セカンドオピニオン市場レポート作成時に参照した一次情報および二次情報です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 2次調査
  • 1次調査
    • 仮説の策定
    • マクロ経済要因分析
    • 基礎数値の作成
    • データの三角測量
    • 国レベルのデータ

第4章 医療セカンドオピニオンの市場情勢

  • PEST分析

第5章 医療セカンドオピニオン市場:主要市場力学

  • 医療セカンドオピニオン市場- 主な市場力学
  • 市場促進要因
    • より良い治療結果への注目の高まり
    • ヘルスケアコストの最適化志向の高まり
  • 市場抑制要因
    • 新興国における医療セカンドオピニオンの認識不足と導入への消極性
  • 市場機会
    • 遠隔医療技術における協力関係の高まり
  • 今後の動向
    • 医療コンサルティングサービスのデジタル化
  • 促進要因と抑制要因の影響

第6章 医療セカンドオピニオン市場:世界市場分析

  • 医療セカンドオピニオン市場の収益、2021年~2031年
  • 医療セカンドオピニオン市場予測分析

第7章 医療セカンドオピニオン市場分析 - 疾患別

  • がん
  • 整形外科疾患
  • 心臓疾患
  • 神経疾患
  • 腎臓疾患
  • 血液疾患
  • COPD(慢性閉塞性肺疾患)
  • 臓器移植
  • その他

第8章 医療セカンドオピニオン市場分析 - サービスプロバイダー別

  • 病院
  • 健康保険会社
  • オンラインサービス

第9章 医療セカンドオピニオン市場分析 - 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • その他中東・アフリカ
  • 中南米
    • ブラジル
    • アルゼンチン
    • その他中南米

第10章 業界情勢

  • 医療セカンドオピニオン市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略
    • 成長戦略

第11章 企業プロファイル

  • Second Opinion International
  • Elite Medical Services
  • The Cigna Group
  • Helsana
  • WorldCare
  • Vidal Health Insurance TPA Pvt Ltd
  • 2nd.MD
  • Axa SA
  • Teladoc Health Inc
  • Included Health, Inc.
  • Royal Doctors

第12章 付録

図表

List Of Tables

  • Table 1. Medical Second Opinion Market Segmentation
  • Table 2. North America: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 3. North America: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 4. United States: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 5. United States: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 6. Canada: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 7. Canada: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 8. Mexico: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 9. Mexico: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 10. Europe: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 11. Europe: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 12. Germany: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 13. Germany: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 14. United Kingdom: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 15. United Kingdom: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 16. France: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 17. France: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 18. Italy: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 19. Italy: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 20. Spain: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 21. Spain: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 22. Rest of Europe: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 23. Rest of Europe: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 24. Asia Pacific: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 25. Asia Pacific: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 26. China: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 27. China: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 28. Japan: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 29. Japan: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 30. India: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 31. India: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 32. Australia: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 33. Australia: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 34. South Korea: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 35. South Korea: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 36. Rest of APAC: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 37. Rest of APAC: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 38. Middle East & Africa: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 39. Middle East & Africa: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 40. Saudi Arabia: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 41. Saudi Arabia: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 42. South Africa: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 43. South Africa: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 44. United Arab Emirates: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 45. United Arab Emirates: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 46. Rest of Middle East & Africa: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 47. Rest of Middle East & Africa: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 48. South & Central America: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 49. South & Central America: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 50. Brazil: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 51. Brazil: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 52. Argentina: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 53. Argentina: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 54. Rest of South & Central America: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Condition
  • Table 55. Rest of South & Central America: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million) - by Service Provider
  • Table 56. Recent Organic Growth Strategies in Medical Second Opinion Market
  • Table 57. Recent Inorganic Growth Strategies in the Medical Second Opinion Market
  • Table 58. Glossary of Terms, Medical Second Opinion Market

List Of Figures

  • Figure 1. Medical Second Opinion Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Medical Second Opinion Market Revenue (US$ Million), 2021-2031
  • Figure 5. Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 6. Medical Second Opinion Market Share (%) - by Condition (2023 and 2031)
  • Figure 7. Cancer: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Orthopedic Disorders: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Cardiac Disorders: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Neurological Disorders: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Nephrological Disorders: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Hematological Blood Disorders: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. COPD: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Organ Transplant: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Others: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Medical Second Opinion Market Share (%) - by Service Provider (2023 and 2031)
  • Figure 17. Hospitals: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Health Insurance Companies: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Online Services: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. North America: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 21. North America: Medical Second Opinion Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 22. United States: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 23. Canada: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 24. Mexico: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 25. Europe: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 26. Europe: Medical Second Opinion Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 27. Germany: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 28. United Kingdom: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 29. France: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 30. Italy: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 31. Spain: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 32. Rest of Europe: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 33. Asia Pacific: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 34. Asia Pacific: Medical Second Opinion Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 35. China: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 36. Japan: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 37. India: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 38. Australia: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 39. South Korea: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 40. Rest of APAC: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 41. Middle East & Africa: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 42. Middle East & Africa: Medical Second Opinion Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 43. Saudi Arabia: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 44. South Africa: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 45. United Arab Emirates: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 46. Rest of Middle East & Africa: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 47. South & Central America: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 48. South & Central America: Medical Second Opinion Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 49. Brazil: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 50. Argentina: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 51. Rest of South & Central America: Medical Second Opinion Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 52. Growth Strategies in Medical Second Opinion Market
目次
Product Code: TIPRE00011728

According to our new research study on "Medical Second Opinion Market Forecast to 2031 -Global Analysis - by Condition, Service Providers, Geography," the market is anticipated to grow from US$ 5.33 billion in 2023 and is projected to reach US$ 15.40 billion by 2031; it is expected to register a CAGR of 14.2% during 2023-2031. The medical second opinion market growth is attributed to the growing emphasis on better treatment outcomes and an increasing preference for healthcare cost optimization.

A medical second opinion is the process through which a patient seeks another professional assessment or evaluation of a diagnosed case, a treatment, or a medical condition by a different provider. This helps patients confirm a diagnosis, seek alternative treatment options, and be reassured about the decisions they make with respect to their health. Getting a second opinion is especially true for serious conditions, complex medical cases, and the uncertainty of a patient in relation to the first recommendation they received. This is apt to empower patients by giving them more information as well as perspectives on their health status.

North America accounted for a major share of the global medical second opinion market in 2023. The North America medical second opinion market is segmented into the US, Canada, and Mexico. Increasing cases of respiratory diseases in the pediatric population and growing investments in medical devices are among a few factors that are projected to accelerate the growth of the medical second opinions market in North America during the forecast period.

In North America, the US holds a significant share of the medical second opinions market. The growth of the market in the country is primarily driven by the increasing prevalence of cancer. Cancer is the second leading cause of death in the country. According to the American Cancer Society, in 2022, more than 1.9 million new cases of cancer were diagnosed in the nation, causing about 609,360 deaths. Further, ~2.0 million people are expected to be diagnosed with cancer in the US in 2024. The increasing number of misdiagnosed cancer cases and its adverse effects are propelling the demand for medical second opinions.

According to research from Johns Hopkins University., ~4,000 surgical errors are caused every year in the US. Further, according to a study, "Top 10 Medical Errors That Lead to Death," ~7,000 to 9,000 patients die due to medication errors each year in the US. According to the article "Burden of serious harms from diagnostic error in the USA," published in July 2023, about 795,000 Americans suffer due to misdiagnosis of serious diseases each year. Such a high number of medical errors is anticipated to surge the country's need for medical second opinion.

In 2017, UnitedHealthcare collaborated with 2nd.MD to provide members with a no-cost, member-focused expert medical opinion service. 2nd.MD virtually connects to a medical opinion service field specialist to review cases and provide a second opinion. In addition, several organizations assist patients by linking them to doctors for reviewing treatment plans, confirming diagnoses, responding to inquiries, and providing rapid second opinions. For instance, WorldCare International Inc. offers the gold standard of medical second opinions for critical illnesses to covered members worldwide. The service covers more than 100 categories of critical illness, including cancer, cardiovascular diseases, neurological disorders, musculoskeletal disorders, and hematology conditions.

Digitalization of Medical Consulting Services to Provide Market Opportunities in Future

The increasing integration of medical services and digital platforms is causing increased popularity and acceptance of digital consultation. This digital platform allows patients to get a second medical opinion without any visit to the hospitals or clinics. The service can provide significant patient convenience, improved patient experience, and effective cost management. Deploying digital platforms enables patients to be consulted from any remote region with better accessibility to medical experts. The increase in collaborations and partnerships between software development companies and healthcare institutions is accelerating the digitalization of medical consulting services. For instance, in October 2021, NorthShore University HealthSystem partnered with TytoCare to help providers diagnose and treat patients using telehealth. NorthShore serves residents across the Chicago metropolitan area and operates six hospitals. In October 2021, Cigna Health Plan announced that it was significantly expanding access to covered virtual care services, including digital-first primary, dermatology, behavioral and urgent care. The growing digitalization of medical consulting services is expected to contribute to the growth of the medical second opinion market in the coming years.

Medical Second Opinion Market: Competitive Landscape and Key Developments

Medisense Healthcare Solutions Pvt. Ltd.; Second Opinion International; Elite Medical Services; The Cigna Group; Helsana; WorldCare; Vidal Health Insurance TPA Pvt Ltd; Medix; 2nd.MD; Axa SA; Teladoc Health Inc; DoctorSpring Pvt. Ltd; USARAD Holdings Inc (SecondOpinions.com); Cleveland Clinic; Included Health, Inc.; Mass General Brigham Incorporated. (Partners Healthcare); Stanford Health Care; and Royal Doctors are among the key companies operating in the medical second opinion market.

The US Food and Drug Administration, American College of Allergy Asthma and Immunology, The Barcelona Institute for Global Health, and Our World in data are among the primary and secondary sources referred to while preparing the medical second opinion market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Medical Second Opinion Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Medical Second Opinion Market - Key Market Dynamics

  • 5.1 Medical Second Opinion Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Growing Emphasis on Better Treatment Outcomes
    • 5.2.2 Increasing Preference for Healthcare Cost Optimization
  • 5.3 Market Restraints
    • 5.3.1 Lack of Awareness and Reluctance Toward Adoption of Medical Second Opinion in Emerging Nations
  • 5.4 Market Opportunities
    • 5.4.1 Rising Collaborations in Telemedicine Technologies
  • 5.5 Future Trends
    • 5.5.1 Digitalization of Medical Consulting Services
  • 5.6 Impact of Drivers and Restraints:

6. Medical Second Opinion Market - Global Market Analysis

  • 6.1 Medical Second Opinion Market Revenue (US$ Million), 2021-2031
  • 6.2 Medical Second Opinion Market Forecast Analysis

7. Medical Second Opinion Market Analysis - by Condition

  • 7.1 Cancer
    • 7.1.1 Overview
    • 7.1.2 Cancer: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Orthopedic Disorders
    • 7.2.1 Overview
    • 7.2.2 Orthopedic Disorders: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Cardiac Disorders
    • 7.3.1 Overview
    • 7.3.2 Cardiac Disorders: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Neurological Disorders
    • 7.4.1 Overview
    • 7.4.2 Neurological Disorders: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Nephrological Disorders
    • 7.5.1 Overview
    • 7.5.2 Nephrological Disorders: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Hematological Blood Disorders
    • 7.6.1 Overview
    • 7.6.2 Hematological Blood Disorders: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.7 COPD
    • 7.7.1 Overview
    • 7.7.2 COPD: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.8 Organ Transplant
    • 7.8.1 Overview
    • 7.8.2 Organ Transplant: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.9 Others
    • 7.9.1 Overview
    • 7.9.2 Others: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)

8. Medical Second Opinion Market Analysis - by Service Provider

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Hospitals: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Health Insurance Companies
    • 8.2.1 Overview
    • 8.2.2 Health Insurance Companies: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Online Services
    • 8.3.1 Overview
    • 8.3.2 Online Services: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)

9. Medical Second Opinion Market - Geographical Analysis

  • 9.1 North America
    • 9.1.1 North America Medical Second Opinion Market Overview
    • 9.1.2 North America: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.1.2.1 North America: Medical Second Opinion Market - Revenue and Forecast Analysis - by Condition
      • 9.1.2.2 North America: Medical Second Opinion Market - Revenue and Forecast Analysis - by Service Provider
    • 9.1.3 North America: Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
      • 9.1.3.1 United States: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.3.1.1 United States: Medical Second Opinion Market Breakdown, by Condition
        • 9.1.3.1.2 United States: Medical Second Opinion Market Breakdown, by Service Provider
      • 9.1.3.2 Canada: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.3.2.1 Canada: Medical Second Opinion Market Breakdown, by Condition
        • 9.1.3.2.2 Canada: Medical Second Opinion Market Breakdown, by Service Provider
      • 9.1.3.3 Mexico: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.3.3.1 Mexico: Medical Second Opinion Market Breakdown, by Condition
        • 9.1.3.3.2 Mexico: Medical Second Opinion Market Breakdown, by Service Provider
  • 9.2 Europe
    • 9.2.1 Europe Medical Second Opinion Market Overview
    • 9.2.2 Europe: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.2.2.1 Europe: Medical Second Opinion Market - Revenue and Forecast Analysis - by Condition
      • 9.2.2.2 Europe: Medical Second Opinion Market - Revenue and Forecast Analysis - by Service Provider
    • 9.2.3 Europe: Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
      • 9.2.3.1 Germany: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.1.1 Germany: Medical Second Opinion Market Breakdown, by Condition
        • 9.2.3.1.2 Germany: Medical Second Opinion Market Breakdown, by Service Provider
      • 9.2.3.2 United Kingdom: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.2.1 United Kingdom: Medical Second Opinion Market Breakdown, by Condition
        • 9.2.3.2.2 United Kingdom: Medical Second Opinion Market Breakdown, by Service Provider
      • 9.2.3.3 France: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.3.1 France: Medical Second Opinion Market Breakdown, by Condition
        • 9.2.3.3.2 France: Medical Second Opinion Market Breakdown, by Service Provider
      • 9.2.3.4 Italy: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.4.1 Italy: Medical Second Opinion Market Breakdown, by Condition
        • 9.2.3.4.2 Italy: Medical Second Opinion Market Breakdown, by Service Provider
      • 9.2.3.5 Spain: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.5.1 Spain: Medical Second Opinion Market Breakdown, by Condition
        • 9.2.3.5.2 Spain: Medical Second Opinion Market Breakdown, by Service Provider
      • 9.2.3.6 Rest of Europe: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.6.1 Rest of Europe: Medical Second Opinion Market Breakdown, by Condition
        • 9.2.3.6.2 Rest of Europe: Medical Second Opinion Market Breakdown, by Service Provider
  • 9.3 Asia Pacific
    • 9.3.1 Asia Pacific Medical Second Opinion Market Overview
    • 9.3.2 Asia Pacific: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.3.2.1 Asia Pacific: Medical Second Opinion Market - Revenue and Forecast Analysis - by Condition
      • 9.3.2.2 Asia Pacific: Medical Second Opinion Market - Revenue and Forecast Analysis - by Service Provider
    • 9.3.3 Asia Pacific: Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
      • 9.3.3.1 China: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.1.1 China: Medical Second Opinion Market Breakdown, by Condition
        • 9.3.3.1.2 China: Medical Second Opinion Market Breakdown, by Service Provider
      • 9.3.3.2 Japan: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.2.1 Japan: Medical Second Opinion Market Breakdown, by Condition
        • 9.3.3.2.2 Japan: Medical Second Opinion Market Breakdown, by Service Provider
      • 9.3.3.3 India: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.3.1 India: Medical Second Opinion Market Breakdown, by Condition
        • 9.3.3.3.2 India: Medical Second Opinion Market Breakdown, by Service Provider
      • 9.3.3.4 Australia: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.4.1 Australia: Medical Second Opinion Market Breakdown, by Condition
        • 9.3.3.4.2 Australia: Medical Second Opinion Market Breakdown, by Service Provider
      • 9.3.3.5 South Korea: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.5.1 South Korea: Medical Second Opinion Market Breakdown, by Condition
        • 9.3.3.5.2 South Korea: Medical Second Opinion Market Breakdown, by Service Provider
      • 9.3.3.6 Rest of APAC: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.6.1 Rest of APAC: Medical Second Opinion Market Breakdown, by Condition
        • 9.3.3.6.2 Rest of APAC: Medical Second Opinion Market Breakdown, by Service Provider
  • 9.4 Middle East & Africa
    • 9.4.1 Middle East & Africa Medical Second Opinion Market Overview
    • 9.4.2 Middle East & Africa: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.4.2.1 Middle East & Africa: Medical Second Opinion Market - Revenue and Forecast Analysis - by Condition
      • 9.4.2.2 Middle East & Africa: Medical Second Opinion Market - Revenue and Forecast Analysis - by Service Provider
    • 9.4.3 Middle East & Africa: Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
      • 9.4.3.1 Saudi Arabia: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.3.1.1 Saudi Arabia: Medical Second Opinion Market Breakdown, by Condition
        • 9.4.3.1.2 Saudi Arabia: Medical Second Opinion Market Breakdown, by Service Provider
      • 9.4.3.2 South Africa: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.3.2.1 South Africa: Medical Second Opinion Market Breakdown, by Condition
        • 9.4.3.2.2 South Africa: Medical Second Opinion Market Breakdown, by Service Provider
      • 9.4.3.3 United Arab Emirates: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.3.3.1 United Arab Emirates: Medical Second Opinion Market Breakdown, by Condition
        • 9.4.3.3.2 United Arab Emirates: Medical Second Opinion Market Breakdown, by Service Provider
      • 9.4.3.4 Rest of Middle East & Africa: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.3.4.1 Rest of Middle East & Africa: Medical Second Opinion Market Breakdown, by Condition
        • 9.4.3.4.2 Rest of Middle East & Africa: Medical Second Opinion Market Breakdown, by Service Provider
  • 9.5 South & Central America
    • 9.5.1 South & Central America Medical Second Opinion Market Overview
    • 9.5.2 South & Central America: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.5.2.1 South & Central America: Medical Second Opinion Market - Revenue and Forecast Analysis - by Condition
      • 9.5.2.2 South & Central America: Medical Second Opinion Market - Revenue and Forecast Analysis - by Service Provider
    • 9.5.3 South & Central America: Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
      • 9.5.3.1 Brazil: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.3.1.1 Brazil: Medical Second Opinion Market Breakdown, by Condition
        • 9.5.3.1.2 Brazil: Medical Second Opinion Market Breakdown, by Service Provider
      • 9.5.3.2 Argentina: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.3.2.1 Argentina: Medical Second Opinion Market Breakdown, by Condition
        • 9.5.3.2.2 Argentina: Medical Second Opinion Market Breakdown, by Service Provider
      • 9.5.3.3 Rest of South & Central America: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.3.3.1 Rest of South & Central America: Medical Second Opinion Market Breakdown, by Condition
        • 9.5.3.3.2 Rest of South & Central America: Medical Second Opinion Market Breakdown, by Service Provider

10. Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in Medical Second Opinion Market
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Inorganic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Second Opinion International
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Elite Medical Services
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 The Cigna Group
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Helsana
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 WorldCare
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Vidal Health Insurance TPA Pvt Ltd
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 2nd.MD
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Axa SA
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Teladoc Health Inc
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Included Health, Inc.
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 Royal Doctors
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Products and Services
    • 11.11.4 Financial Overview
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms